These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 29894844)
1. Atorvastatin enhances endothelial adherens junctions through promoting VE-PTP gene transcription and reducing VE-cadherin-Y731 phosphorylation. Huo Z; Kong Y; Meng M; Cao Z; Zhou Q Vascul Pharmacol; 2019 Jun; 117():7-14. PubMed ID: 29894844 [TBL] [Abstract][Full Text] [Related]
2. Pyk2 phosphorylation of VE-PTP downstream of STIM1-induced Ca Soni D; Regmi SC; Wang DM; DebRoy A; Zhao YY; Vogel SM; Malik AB; Tiruppathi C Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L1003-L1017. PubMed ID: 28385807 [TBL] [Abstract][Full Text] [Related]
3. HIF2α signaling inhibits adherens junctional disruption in acute lung injury. Gong H; Rehman J; Tang H; Wary K; Mittal M; Chaturvedi P; Zhao YY; Komarova YA; Vogel SM; Malik AB J Clin Invest; 2015 Feb; 125(2):652-64. PubMed ID: 25574837 [TBL] [Abstract][Full Text] [Related]
4. VE-PTP stabilizes VE-cadherin junctions and the endothelial barrier via a phosphatase-independent mechanism. Juettner VV; Kruse K; Dan A; Vu VH; Khan Y; Le J; Leckband D; Komarova Y; Malik AB J Cell Biol; 2019 May; 218(5):1725-1742. PubMed ID: 30948425 [TBL] [Abstract][Full Text] [Related]
5. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin. Frye M; Dierkes M; Küppers V; Vockel M; Tomm J; Zeuschner D; Rossaint J; Zarbock A; Koh GY; Peters K; Nottebaum AF; Vestweber D J Exp Med; 2015 Dec; 212(13):2267-87. PubMed ID: 26642851 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2. Hatanaka K; Lanahan AA; Murakami M; Simons M PLoS One; 2012; 7(5):e37600. PubMed ID: 22629427 [TBL] [Abstract][Full Text] [Related]
7. Atorvastatin preserves the integrity of endothelial adherens junctions by inhibiting vascular endothelial cadherin tyrosine phosphorylation. Haidari M; Zhang W; Chen Z; Ganjehei L; Mortazavi A; Warier N; Vanderslice P; Dixon RA Exp Cell Res; 2012 Aug; 318(14):1673-84. PubMed ID: 22659162 [TBL] [Abstract][Full Text] [Related]
8. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. Nottebaum AF; Cagna G; Winderlich M; Gamp AC; Linnepe R; Polaschegg C; Filippova K; Lyck R; Engelhardt B; Kamenyeva O; Bixel MG; Butz S; Vestweber D J Exp Med; 2008 Nov; 205(12):2929-45. PubMed ID: 19015309 [TBL] [Abstract][Full Text] [Related]
9. Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine. Starosta V; Wu T; Zimman A; Pham D; Tian X; Oskolkova O; Bochkov V; Berliner JA; Birukova AA; Birukov KG Am J Respir Cell Mol Biol; 2012 Mar; 46(3):331-41. PubMed ID: 21997484 [TBL] [Abstract][Full Text] [Related]
10. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. Nawroth R; Poell G; Ranft A; Kloep S; Samulowitz U; Fachinger G; Golding M; Shima DT; Deutsch U; Vestweber D EMBO J; 2002 Sep; 21(18):4885-95. PubMed ID: 12234928 [TBL] [Abstract][Full Text] [Related]
11. Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2. Drexler HCA; Vockel M; Polaschegg C; Frye M; Peters K; Vestweber D Mol Cell Proteomics; 2019 Oct; 18(10):2058-2077. PubMed ID: 31427368 [TBL] [Abstract][Full Text] [Related]
12. How T cells trigger the dissociation of the endothelial receptor phosphatase VE-PTP from VE-cadherin. Vockel M; Vestweber D Blood; 2013 Oct; 122(14):2512-22. PubMed ID: 23908467 [TBL] [Abstract][Full Text] [Related]
13. PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity. Vandenbroucke St Amant E; Tauseef M; Vogel SM; Gao XP; Mehta D; Komarova YA; Malik AB Circ Res; 2012 Aug; 111(6):739-49. PubMed ID: 22798526 [TBL] [Abstract][Full Text] [Related]
14. Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. Broermann A; Winderlich M; Block H; Frye M; Rossaint J; Zarbock A; Cagna G; Linnepe R; Schulte D; Nottebaum AF; Vestweber D J Exp Med; 2011 Nov; 208(12):2393-401. PubMed ID: 22025303 [TBL] [Abstract][Full Text] [Related]
15. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions. Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220 [TBL] [Abstract][Full Text] [Related]
16. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. Adam AP; Sharenko AL; Pumiglia K; Vincent PA J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167 [TBL] [Abstract][Full Text] [Related]
17. Dissecting the Cellular Mechanism of Prostacyclin Analog Iloprost in Reversing Vascular Dysfunction in Scleroderma. Tsou PS; Palisoc PJ; Flavahan NA; Khanna D Arthritis Rheumatol; 2021 Mar; 73(3):520-529. PubMed ID: 33001586 [TBL] [Abstract][Full Text] [Related]